RTRAF and colorectal carcinoma: In 2024, by functional genomics studies employing CRISPR-Cas9, Metrnβ was identified as a susceptibility gene alongside TRPS1 and C14orf166 for CRC, demonstrating oncogenic properties through enhanced cell proliferation and migration in CRC cell lines [79].